Sponsor
Tongji University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Tongji University appears in 24 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
24 shownA Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationsNCT07361237 · lead sponsor · 2025-12-30
RECRUITINGMechanistic Studies of Chronic COPD Using Single-Cell Sequencing and Single-Cell Spatial TranscriptomicsNCT07208123 · lead sponsor · 2025-09-30
NOT_YET_RECRUITINGtACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.NCT07074704 · lead sponsor · 2025-06-11
ENROLLING_BY_INVITATIONThe Regulatory Function of Inhaled Asthma Medication Salbutamol on ThermogenesisNCT06319183 · lead sponsor · 2024-03-01
UNKNOWNA Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT06276933 · lead sponsor · 2024-02-22
NOT_YET_RECRUITINGIntra-cortical Inhibition and Cognitive Deficits in SchizophreniaNCT05542212 · lead sponsor · 2022-09-28
UNKNOWNAdjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung CarcinomaNCT05165355 · lead sponsor · 2021-12-28
UNKNOWNA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNCT05157776 · lead sponsor · 2021-10-28
UNKNOWNThe Effect of a Combined Drainage Strategy in Uniportal Upper Lung LobectomyNCT04461652 · lead sponsor · 2020-01-05
UNKNOWNPrevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone PropionateNCT03886441 · lead sponsor · 2019-04-01
UNKNOWNThe Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung CancerNCT02515435 · lead sponsor · 2015-01-01
UNKNOWNEfficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung CancerNCT02535507 · lead sponsor · 2015-01-01
UNKNOWNStudy of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung CancerNCT02540824 · lead sponsor · 2015-01-01
UNKNOWNTranscutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer PatientsNCT02663492 · lead sponsor · 2014-08-01
UNKNOWNThe Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung CancerNCT02262897 · lead sponsor · 2013-09-01
UNKNOWNMaintenance Gemcitabine in the Chinese Advanced Lung CancerNCT01336192 · lead sponsor · 2011-04-01
UNKNOWNIndividualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)NCT01424709 · lead sponsor · 2010-12-01
UNKNOWNErlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 MutationNCT00874419 · lead sponsor · 2008-08-01
COMPLETEDThe Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionNCT00718952 · lead sponsor · 2008-07-01
COMPLETEDEfficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's DiseaseNCT05538507 · collaborator · 2022-06-01
UNKNOWNAF Ablation for HF With Reduced EFNCT05827172 · collaborator · 2020-06-01
COMPLETEDAutologous Bronchial Basal Cell Transplantation for Treatment of COPDNCT03188627 · collaborator · 2018-06-12
COMPLETEDTreatment of COPD by Autologous Transplantation of Bronchial Basal CellsNCT03156673 · collaborator · 2017-04-01
UNKNOWNAutologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)NCT03092648 · collaborator · 2017-03-01
UNKNOWNDrugs studied in this sponsor's trials
8 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Tongji University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo2
albuterol1
donepezil1
erlotinib1
gemcitabine1
memantine1
paclitaxel protein-bound1
vardenafil1
placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
2 trials
albuterol RxCUI 435 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
donepezil RxCUI 135447 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
erlotinib RxCUI 337525 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
gemcitabine RxCUI 12574 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
memantine RxCUI 6719 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
paclitaxel protein-bound RxCUI 486610 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
vardenafil RxCUI 306674 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor19
collaborator5
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.